Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001439222-26-000073
Filing Date
2026-04-29
Accepted
2026-04-29 09:22:14
Documents
69
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q agio-20260331.htm   iXBRL 10-Q 1139169
2 EX-10.1 agio-ex101x033126.htm EX-10.1 55668
3 EX-31.1 agio-ex311x03x31x26.htm EX-31.1 9551
4 EX-31.2 agio-ex312x03x31x26.htm EX-31.2 9562
5 EX-32.1 agio-ex321x03x31x26.htm EX-32.1 4620
6 EX-32.2 agio-ex322x03x31x26.htm EX-32.2 4615
  Complete submission text file 0001439222-26-000073.txt   5817733

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT agio-20260331.xsd EX-101.SCH 39691
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT agio-20260331_cal.xml EX-101.CAL 66679
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT agio-20260331_def.xml EX-101.DEF 150397
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT agio-20260331_lab.xml EX-101.LAB 537583
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT agio-20260331_pre.xml EX-101.PRE 370684
73 EXTRACTED XBRL INSTANCE DOCUMENT agio-20260331_htm.xml XML 717617
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Filer) CIK: 0001439222 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36014 | Film No.: 26910950
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)